Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
Schuhmacher J, Kaul S, Klivényi G, Junkermann H, Magener A, Henze M, Doll J, Haberkorn U, Amelung F, Bastert G.
Schuhmacher J, et al.
Cancer Res. 2001 May 1;61(9):3712-7.
Cancer Res. 2001.
PMID: 11325843
Clinical Trial.
Pretargeting techniques that are based on the sequential administrations of bispecific antitumor/antimetal chelate antibodies (BS-MAbs), a blocker to saturate the anti-chelate binding sites of the BS-MAb still present in the circulation, and the radiolabeled chelate are su …
Pretargeting techniques that are based on the sequential administrations of bispecific antitumor/antimetal chelate antibodies (BS-MAb …